Primary biliary cirrhosis: From bench to bedside.
Primary biliary cirrhosis (PBC) is a chronic non-suppurative destructive intrahepatic cholangitis leading to cirrhosis after a protractive non cirrhotic stage. The etiology and pathogenesis are largely unknown and autoimmne mechanisms have been implicated to explain the pathological lesions. Many epitopes and autoantigens have been reported as crucial in the pathophysiology of the disease and T and B cells abnormalities have been described, the exact pathways leading to the destruction of small intrahepatic ductules are mostly speculative. In this review we examined the various epidemiologal and geoepidemiological data as well as the complex pathogenetic aspects of this disease, focusing on recent in vivo and in vitro studies in this field. Initiation and progression of PBC is believed to be a multifactorial process with strong infuences from the patient's genetic background and by various environmental factors. The role of innate and adaptive immunity, including cytokines, chemokines, macrophages and the involvement of apoptosis and reactive oxygen species are outlined in detailed. The current pathogenetic aspects are presented and a novel pathogenetic theory unifying the accumulated clinical information with in vitro and in vivo data is formulated. A review of clinical manifestations and immunological and pathological diagnosis was presented. Treatment modalities, including the multiple mechanisms of action of ursodeoxycholate were finally discussed.
Elias Kouroumalis, Department of Gastroenterogy and Hepatology, University of Crete Medical School, 71003 Heraklion, Crete, Greece.
Elias
E
Kouroumalis
Elias Kouroumalis, Department of Gastroenterogy and Hepatology, University of Crete Medical School, 71003 Heraklion, Crete, Greece.
George
G
Notas
Adaptive immunity; Chemokines; Cytokines; Innate immunity; Macrophages; Primary biliary cirrhosis; Ursodeoxycholate